Cardiovascular
Cardiovascular(心血管)
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
- Acute Phase Reactants(17)
- Angina(14)
- Arrhythmia(85)
- Atherosclerosis(93)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(46)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(131)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(10)
- Endothelium(35)
- Erythrocytes & Hemoglobin(53)
- Heart Failure(32)
- Hypertension(167)
- Hypotension(24)
- Lipoproteins(66)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(64)
- Others(53)
- Serum Proteins(11)
- Smooth Muscle Cells(37)
- Storage & Transport(6)
- Stroke(53)
- Vasoconstriction(61)
- Thrombosis(58)
- Vasodilation(146)
Cardiovascular 相关产品(860)
- GC40230Deferasirox-d4CAS: 1133425-75-8纯度: >99.00%
An internal standard for the quantification of deferasirox
- GC40231Milrinone-d3CAS: 2749393-50-6纯度: >99.00%
An internal standard for the quantification of milrinone
- GC40234Ramipril-d5CAS: 1132661-86-9纯度: >99.00%
An internal standard for the quantification of ramipril
- GC40235Ranolazine-d5CAS: 1092804-87-9纯度: >99.00%
An internal standard for the quantification of ranolazine
- GC40239Limaprost-d3CAS: 1263190-37-9纯度: >99.00%
An internal standard for the quantification of limaprost
- GC403365-cis CarbaprostacyclinCAS: 69609-77-4纯度: >99.00%
A stable analog of PGI 2 that weakly inhibits platelet aggregation
- GC403389-deoxy-9-methylene Prostaglandin E2CAS: 61263-32-9纯度: >98.00%
A stable, isosteric analog of PGE 2
- GC404185β,6β-epoxy CholestanolCAS: 4025-59-6纯度: >95.00%
An oxidative metabolite of cholesterol
- GC40434(±)16-HETECAS: 128914-46-5纯度: >98.00%
A potent inhibitor of proximal tubule ATPase activity
- GC40438(±)5(6)-EETCAS: 87173-80-6纯度: >95.00%
A racemic version of a CYP450 metabolite of arachidonic acid
- GC40444(5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic AcidCAS: 339534-01-9纯度: >98.00%
A stable isomer of 15(S)-HETE
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC40230 | Deferasirox-d4 | 1133425-75-8 | >99.00% | |
An internal standard for the quantification of deferasirox | ||||
| GC40231 | Milrinone-d3 | 2749393-50-6 | >99.00% | |
An internal standard for the quantification of milrinone | ||||
| GC40234 | Ramipril-d5 | 1132661-86-9 | >99.00% | |
An internal standard for the quantification of ramipril | ||||
| GC40235 | Ranolazine-d5 | 1092804-87-9 | >99.00% | |
An internal standard for the quantification of ranolazine | ||||
| GC40239 | Limaprost-d3 | 1263190-37-9 | >99.00% | |
An internal standard for the quantification of limaprost | ||||
| GC40268 | (±)14(15)-DiHET | - | >98.00% | |
A urinary metabolite of (±)14(15)-EET | ||||
| GC40336 | 5-cis Carbaprostacyclin | 69609-77-4 | >99.00% | |
A stable analog of PGI 2 that weakly inhibits platelet aggregation | ||||
| GC40338 | 9-deoxy-9-methylene Prostaglandin E2 | 61263-32-9 | >98.00% | |
A stable, isosteric analog of PGE 2 | ||||
| GC40340 | Prostaglandin A1 methyl ester | 26771-94-8 | - | |
Lipophilic analog of PGA 1 | ||||
| GC40356 | (±)9-HpODE | 5502-91-0 | >98.00% | |
A plant oxylipin | ||||
| GC40362 | (±)18-HEPE | 141110-17-0 | >95.00% | |
Non-enzymatic oxidation product of EPA | ||||
| GC40386 | (±)11(12)-EpETE | 504435-15-8 | >98.00% | |
Epoxygenase metabolite of EPA | ||||
| GC40417 | 19-hydroxy Cholesterol | 561-63-7 | >98.00% | |
An oxysterol | ||||
| GC40418 | 5β,6β-epoxy Cholestanol | 4025-59-6 | >95.00% | |
An oxidative metabolite of cholesterol | ||||
| GC40421 | (±)8(9)-EE-14(Z)-E | - | >95.00% | |
A by-product from the synthesis of (±)14(15)-EE-8(Z)-E | ||||
| GC40424 | 14,15-EE-5(Z)-E | 519038-92-7 | >98.00% | |
An antagonist of EDHF-mediated vasodilation | ||||
| GC40425 | 14,15-EE-8(Z)-E | 519038-93-8 | >98.00% | |
A potent vasodilator | ||||
| GC40430 | (±)14(15)-EET | 197508-62-6 | >98.00% | |
An arachidonic acid metabolite | ||||
| GC40434 | (±)16-HETE | 128914-46-5 | >98.00% | |
A potent inhibitor of proximal tubule ATPase activity | ||||
| GC40436 | (±)18-HETE | 133268-58-3 | >97.00% | |
A vasodilator of renal arterioles | ||||
| GC40437 | (±)5(6)-DiHET lactone | 213126-92-2 | >98.00% | |
A lactone form of (±)5(6)-DiHET | ||||
| GC40438 | (±)5(6)-EET | 87173-80-6 | >95.00% | |
A racemic version of a CYP450 metabolite of arachidonic acid | ||||
| GC40443 | (±)9-HETE | 79495-85-5 | >98.00% | |
A monohydroxy fatty acid | ||||
| GC40444 | (5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic Acid | 339534-01-9 | >98.00% | |
A stable isomer of 15(S)-HETE | ||||